Incidence and outcomes of hospital-associated coronavirus disease 2019 (COVID-19) before and after emergence of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant
- PMID: 36876324
- PMCID: PMC10587372
- DOI: 10.1017/ice.2023.29
Incidence and outcomes of hospital-associated coronavirus disease 2019 (COVID-19) before and after emergence of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant
Conflict of interest statement
Dr. Leis has received payment for expert testimony as requested by hospitals of the Ontario Hospital Association, Ministry of Attorney General of Ontario, and Seneca College. All other authors have no conflicts of interest related to this research.
References
-
- Williams VR, Chan CK, Chan AK, et al. Impact of universal admission testing for severe acute respiratory coronavirus 2 (SARS-CoV-2) in era of the omicron variant. Infect Control Hosp Epidemiol 2023;44:102–105. - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
